USSIA, GIAN PAOLO
 Distribuzione geografica
Continente #
AS - Asia 12.029
NA - Nord America 2.910
EU - Europa 1.446
SA - Sud America 85
OC - Oceania 71
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.572
Nazione #
SG - Singapore 8.324
US - Stati Uniti d'America 2.806
HK - Hong Kong 1.924
CN - Cina 1.534
GB - Regno Unito 457
IT - Italia 306
DE - Germania 216
NL - Olanda 110
IN - India 92
CA - Canada 83
EE - Estonia 80
AU - Australia 68
BR - Brasile 63
CZ - Repubblica Ceca 56
FI - Finlandia 39
JP - Giappone 30
TR - Turchia 29
FR - Francia 27
UA - Ucraina 26
ES - Italia 24
ZA - Sudafrica 20
ID - Indonesia 19
VN - Vietnam 18
PL - Polonia 17
MX - Messico 16
LT - Lituania 13
SE - Svezia 13
AT - Austria 10
IR - Iran 10
BD - Bangladesh 7
HU - Ungheria 7
RO - Romania 7
CL - Cile 6
IL - Israele 6
CH - Svizzera 5
CO - Colombia 5
MA - Marocco 5
RU - Federazione Russa 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
AR - Argentina 4
BG - Bulgaria 4
PK - Pakistan 4
SA - Arabia Saudita 4
TH - Thailandia 4
BE - Belgio 3
IE - Irlanda 3
KR - Corea 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PE - Perù 3
SI - Slovenia 3
AL - Albania 2
AZ - Azerbaigian 2
CU - Cuba 2
EC - Ecuador 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
PH - Filippine 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
PA - Panama 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 16.572
Città #
Hong Kong 1.905
Ashburn 901
Hefei 882
Singapore 814
Boardman 528
London 387
Shanghai 299
Dallas 197
Beijing 148
Los Angeles 115
Rome 87
Amsterdam 82
San Francisco 82
Council Bluffs 80
Munich 70
West Jordan 61
Tallinn 49
Pune 47
Seattle 43
Toronto 41
Brno 40
Santa Clara 38
Washington 37
New York 34
Tokyo 29
Brooklyn 27
Milan 27
Montreal 24
Turku 24
Chicago 23
Perth 20
São Paulo 20
Curitiba 19
Boston 18
Melbourne 15
Frankfurt am Main 14
Helsinki 14
Olomouc 14
Canberra 13
The Dalles 13
Sydney 12
Warsaw 12
Buffalo 11
Hanover 11
Hangzhou 10
Manchester 10
Mexico City 10
Sona 10
Stockholm 10
Xi'an 10
Bengaluru 9
Jinan 9
Johannesburg 9
Berlin 8
Charlotte 8
Haikou 8
Secaucus 8
Madrid 7
Surat 7
Zhengzhou 7
Atlanta 6
Bologna 6
Boydton 6
Central 6
Chennai 6
Nuremberg 6
Oxford 6
Vienna 6
Zhoukou 6
Ankara 5
Ho Chi Minh City 5
Las Vegas 5
Oklahoma City 5
Paris 5
Phoenix 5
Qingdao 5
Shenzhen 5
Budapest 4
Cherry Hill 4
Denver 4
Florence 4
Freiburg im Breisgau 4
Guangzhou 4
Ponta Grossa 4
Riyadh 4
Santiago 4
Springfield 4
Târgu Mureş 4
Aubin Grove 3
Calgary 3
Casablanca 3
Conroe 3
Dublin 3
Hyderabad 3
Kowloon City 3
Krakow 3
Lima 3
Lincoln 3
Ljubljana 3
Luxembourg 3
Totale 7.641
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 409
[Percutaneous repair of mitral regurgitation: a new tool in the armamentarium for advanced heart failure?] 231
HEART VALVE STUDY GROUP CATHQUEST 2011 217
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 210
Valve-in-valve technique fixes leaks after TAVI 208
Valve-in-Valve’ Technique Effective in Treating CoreValve Leaks 207
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence 204
A case series of treatment of coronary trifurcation with a new technique: " the modified double crush technique" 204
[Multidisciplinary position paper on the management of patent foramen ovale in the presence of cryptogenic cerebral ischemia - Italian version 2013]. 202
HEART VALVE STUDY GROUP CATHQUEST 12 APRIL 2013 https://www.cathquest.com 201
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 200
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 200
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 198
A NOVEL APPROACH TO DEFINE RISK OF STENT THROMBOSIS AFTER PERCUTANEOUS CORONARY INTERVENTION WITH DRUG ELUTING STENTS: THE DERIVATION SCORE 194
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 193
30 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study 193
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 191
Carcinoid Pulmonary Valve Stenosis: Multimodality Imaging and Transcatheter Valve Implant With Prestenting Technique 187
3D transesophageal echocardiographic assessment of acute reverse remodeling of the tricuspid annulus after transcatheter edge-to-edge repair 185
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis 185
Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A Contemporary Reappraisal 185
LIVE CASE TRANSCATHETER MITRAL VALVE TREATMENT FROM FERRAROTTO HOSPITAL CATANIA ITALY TO VALVE SUMMIT SANTA TECLA (CT) 30 APRIL 2010 185
Acute pharmacological tests in patients with primary and precapillary secondary pulmonary hypertension 184
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients 183
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 183
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 180
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when? 175
Andamento dei livelli plasmatici dei neurormoni dopo il trapianto cardiaco 174
1-year results of the subclavian access for tavi with the corevalve bioprosthesis in 132 consecutive patients 166
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 166
Current management and prognosis of patients with recurrent myocardial infarction 163
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 152
Percutaneous Left Atrial Appendage Closure: Acute Effects on Left Atrial Pressure in Humans 150
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 140
Intracardiac echocardiography with ultrasound probe placed in the upper left pulmonary vein to guide left atrial appendage closure: First description 136
Cardiovascular and metabolic effects of hyperbilirubinemia in a cohort of Italian Olympic athletes 126
Advances in Transcatheter Aortic Valve Therapy in Bicuspid Aortic Valve Disease: Insight into Patient Selection, Management, and Future Directions 106
expert roundtable » Present and Future Challenges in Transcatheter Aortic Valve Replacement 105
A novel tricuspid flow optimiser for severe tricuspid regurgitation (TRiFlO) 99
Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study 98
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 95
Impact of endothelial dysfunction on long-term clinical outcomes in patients with chronic coronary syndromes treated with second generation drug-eluting stent implantation 95
ACCURACY OF INTRACARDIAC ECHOCARDIOGRAPHY FOR AORTIC ROOT ASSESSMENT IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE IMPLANTATION 95
TAVR LIVE CASE WITH COREVALVE AT 16TH ANNUAL SYMPOSIUM OF LIVE SYMPOSIUM OF COMPLEX CORONARY, VALVULAR AND VASCULAR CASES, NEW YORK, NEW YORK, USA 14TH JUNE 2013 93
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 92
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 91
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 91
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 90
3-year outcomes of self-expanding Corevalve prosthesis - The Italian Registry 90
ACQUIRED PULMONARY VEIN OBSTRUCTION AFTER OPEN HEART SURGERY 88
2-YEAR RESULTS OF COREVALVE IMPLANTATION THROUGH THE SUBCLAVIAN ACCESS: A PROPENSITY-MATCHED COMPARISON WITH THE FEMORAL ACCESS 85
Analisi dei tests farmacologici acuti nei pazienti con ipertensione arteriosa polmonare precapillare 84
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 84
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 83
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 82
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 79
ALTRE INDICAZIONI 77
Invasive Assessment of Coronary Microvascular Function 76
"Finding the biomarker" for transcatheter mitral valve repair. Eur J Heart Fail. 2019 75
ACCURACY OF INTRACARDIAC ECHOCARDIOGRAPHY FOR AORTIC ROOT ASSESSMENT IN PATIENTS CANDIDATED TO TRANSCATHETER AORTIC VALVE IMPLANTATION 74
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 71
The Spectrum of Coronary Artery Disease in Elite Endurance Athletes-A Long-Standing Debate: State-of-the-Art Review 68
Relation of endothelin-1 to survival in patients with primary pulmonary hypertension 65
Relazione comparativa tra capacità funzionale e profilo emodinamico in pazienti con scompenso cardiaco cronico biventricolare o scompenso cardiaco destro puro 63
Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: Results of the multicenter Italian OBSERVANT Registry. 60
6 Months’ Follow-Up of the First-in-Man Implantation of a Novel Tricuspid Flow Optimizer 59
Classification of Aortic Stenosis Patients via ECG-Independent Multi-Site Measurements of Cardiac-Induced Accelerations and Angular Velocities at the Skin Level 59
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 46
Systematic review and meta-analysis of randomized and nonrandomized studies on fractional flow reserve-guided revascularization 44
Eosinophilic Myocarditis: From Bench to Bedside 40
Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention 38
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 38
Severe heart failure and intracardiac thrombosis: going beyond the appearance for diagnosis and treatments 37
Traditional and Advanced Echocardiographic Evaluation in Chronic Obstructive Pulmonary Disease: The Forgotten Relation 35
EVALUATION OF THE MORPHOLOGY OF THE OVAL FOSSA FOR PLACEMENT OF DEVICES 33
LIVE CASE TRANSCATHETER AORTIC VALVE IMPLANTATIONFROM FERRAROTTO HOSPITAL CATANIA ITALY TO PADOVA AORTIC VALVE REPAIR CONFERENCE 9TH OCTOBER 2009 32
P15 - usefulness of the amplatzer multi-fenestrated septal occluder - "cribriform" for patent foramen ovale and multifenestrated atrial septal aneurism: institutional experience 32
Percutaneous Mitral Valve Interventions in the Real World: Early and One Year Results From the ACCESS-EU, a Prospective, Multicenter, Non-Randomized Post-Approval Study of the MitraClip® Therapy in Europe 31
Transcatheter Tricuspid Valve Therapy: From Anatomy to Intervention 30
P17-Utilizzo di protesi ASD Amplatzer di diametro maggiore 38 MM in pazienti con DIA di grandi dimensioni 30
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 29
EARLY AND MID-TERM OUTCOMES OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN PATIENTS WITH LOGISTIC EUROSCORE LESS THAN 20%: A COMPARATIVE ANALYSIS BETWEEN DIFFERENT RISK STRATA 29
L'attività neuroadrenergica nella sindrome da prolasso valvolare mitralico e nei soggetti normali 29
Meta-Analysis Comparing Single Versus Dual Antiplatelet Therapy Following Transcatheter Aortic Valve Implantation. 29
Tricuspid Valve Geometrical Changes in Patients with Functional Tricuspid Regurgitation: Insights from a CT Scan Analysis Focusing on Commissures 28
Watchful surgery in asymptomatic mitral valve prolapse 28
Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality-A Comprehensive Review 28
Indirect respiratory monitoring via single-lead wearable ECG: Influence of motion artifacts and devices on respiratory rate estimations 28
Usefulness of the amplatzer multi-fenestrated septal occluder cribriform for patent foramen ovale and multifenestrated atrial septal aneurism: institutional experience 28
LIVE CASE TRANSCATHETER AORTIC VALVE IMPLANTATION FROM FERRAROTTO HOSPITAL CATANIA ITALY TOSOCIETY ITALIAN CARDIOLOGY NATIONAL CONGRESS ROME 13 DECEMBER 2008 28
Mitral and Tricuspid Valves Percutaneous Repair in Patients with Advanced Heart Failure: Panacea, or Pandora's Box? 27
Differenza tra i sessi nella massa del ventricolo destro dei pazienti con ipertensione arteriosa polmonare primitiva 27
Impact of preprocedural left ventricular ejection fraction on 1-year outcomes after mitraclip implantation (from the ACCESS-EU Phase I, a prospective, multicenter, nonrandomized postapproval study of the mitraclip therapy in Europe) 27
CORRECTION OF MITRAL REGURGITATION IN NONRESPONDERS TO CARDIAC RESYNCHRONIZARTION THERAPY BY MITRACLIP IMPROVES SYMPTOMS AND PROMOTES REVERSE REMODELING 27
Cardiovascular medicine heart failure (CVM-HF) index as prognostic model for candidates to MitraClip therapy. 27
Leiomatosi intravenosa con interessamento cardiaco: diagnosi e follow-up ecocardiografico 27
The butterfly effect: Restoring the tricuspid coaptation after clipping the antero-septal commissure 26
Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis 26
Percutaneous Repair of Atrial Functional Tricuspid Regurgitation in Cardiac Amyloidosis: Combining Linear With Lateral Thinking 26
Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease 26
Totale 10.455
Categoria #
all - tutte 151.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022509 0 0 14 8 3 9 7 10 6 22 11 419
2022/2023206 7 9 21 17 20 8 9 13 2 0 97 3
2023/20241.763 43 149 62 146 134 590 54 303 56 106 41 79
2024/202512.396 261 150 517 174 108 376 195 62 1.148 1.077 4.067 4.261
2025/20261.792 1.202 474 116 0 0 0 0 0 0 0 0 0
Totale 16.666